Lactate Metabolic Reprogramming Reverses CD8⁺ T Cell Exhaustion: A New Target for Cancer Immunotherapy
Global Health Care · 08.11.2026 · 2 (1) · 1-36
DOI: 10.63808/ghc.v2i1.535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Health Care, online erschienen am 08.11.2026. Verfasst von Gang Liu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lactate accumulation in the tumor microenvironment is an important factor inducing CD8⁺ T cell exhaustion and immunotherapy resistance, but whether reprogramming lactate metabolism can reverse CD8⁺ T cell exhaustion remains unclear. This study aims to explore the effects of targeted lactate metabolism on CD8⁺ T cell function and anti-tumor immunotherapy. Single-cell RNA sequencing, metabolomics, flow cytometry, and immunohistochemistry were used to analyze the lactate metabolism characteristics and exhaustion phenotypes of tumor-infiltrated CD8⁺ T cells; Genetics or pharmacological methods were used to regulate lactate dehydrogenase A (LDHA) and the lactate transporter MCT1/4, and to evaluate anti-tumor effects and synergistic effects with anti-PD-1 therapy in tumor-bearing mouse models of B16-OVA and MC38. Lactate uptake in tumor-infiltrating CD8⁺ T cells increases, with significant upregulation of MCT1/4 and LDHA, accompanied by decreased mitochondrial membrane potential, impaired oxidative phosphorylation, and increased expression of depletion markers such as PD-1, TIM-3, LAG-3, and TOX/NR4A. Inhibiting LDHA or blocking MCT1/4 lowers intracellular lactate levels, restores mitochondrial function and oxidative phosphorylation, enhances secretion of IFN-γ, TNF-α, and granzyme B, and downregulates depletion-related transcriptional programs. In tumor-bearing mice, reprogramming of lactate metabolism significantly inhibits tumor growth, increases the proportion of tumor-infiltrating CD8⁺ T cells and effector memory phenotypes, and produces synergistic effects with anti-PD-1 therapy. Mechanistically, lactate regulates the expression of exhaustion-related genes through histone lactation modification, while metabolic intervention can reverse this epigenetic program. Targeted lactate metabolism reprogramming can effectively reverse CD8⁺ T cell exhaustion, enhance the efficacy of tumor immunotherapy, and provide new potential targets for solid tumor immunotherapy.
Zitieren
APA
Liu, G., Wang, J., Vasiukevich, A. M., Feng, B., & An, L. (2026). Lactate Metabolic Reprogramming Reverses CD8⁺ T Cell Exhaustion: A New Target for Cancer Immunotherapy. Global Health Care, 2(1), 1-36. https://doi.org/10.63808/ghc.v2i1.535
Vancouver
Liu G, Wang J, Vasiukevich AM, Feng B, An L. Lactate Metabolic Reprogramming Reverses CD8⁺ T Cell Exhaustion: A New Target for Cancer Immunotherapy. Global Health Care. 2026;2(1):1-36. doi:10.63808/ghc.v2i1.535
BibTeX
@article{Liu2026,
author = {Liu, Gang and Wang, Jia and Vasiukevich, Alena Mikalaeuna and Feng, Biao and An, Liqiang},
title = {Lactate Metabolic Reprogramming Reverses CD8⁺ T Cell Exhaustion: A New Target for Cancer Immunotherapy},
journal = {Global Health Care},
year = {2026},
volume = {2},
number = {1},
pages = {1--36},
doi = {10.63808/ghc.v2i1.535}
}
EUVIMED